X-53291927-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001111125.3(IQSEC2):c.708-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000012 in 1,164,030 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001111125.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IQSEC2 | NM_001111125.3 | c.708-3C>T | splice_region_variant, intron_variant | ENST00000642864.1 | NP_001104595.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IQSEC2 | ENST00000642864.1 | c.708-3C>T | splice_region_variant, intron_variant | NM_001111125.3 | ENSP00000495726.1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111852Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34028
GnomAD3 exomes AF: 0.0000175 AC: 2AN: 114265Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 40689
GnomAD4 exome AF: 0.0000124 AC: 13AN: 1052127Hom.: 0 Cov.: 28 AF XY: 0.00000875 AC XY: 3AN XY: 342977
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111903Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 34089
ClinVar
Submissions by phenotype
Tip-toe gait Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino | - | Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 04, 2020 | The c.708-3C>T intronic alteration results from a C to T substitution 3 nucleotides before coding exon 2 of the IQSEC2 gene. Based on data from the Genome Aggregation Database (gnomAD) database, the IQSEC2 c.708-3C>T alteration was observed in 0.00175% (2/114,265) of total alleles studied, with a frequency of 0.0045% (2/44,211) in the European (non-Finnish) subpopulation. This nucleotide position is conserved in available mammalian species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Intellectual disability, X-linked 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 06, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. ClinVar contains an entry for this variant (Variation ID: 567855). This variant has been observed in individual(s) with IQSEC2-related conditions (Invitae). This variant is present in population databases (rs781873807, gnomAD 0.005%). This sequence change falls in intron 1 of the IQSEC2 gene. It does not directly change the encoded amino acid sequence of the IQSEC2 protein. It affects a nucleotide within the consensus splice site. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at